Skip to main content
. 2020 Jan 15;12(1):92–100. doi: 10.4251/wjgo.v12.i1.92

Table 2.

Baseline characteristics of patients after treatment

Characteristics 3 d after treatment
Laboratory values, median (range)
WBC count, 109/L 4.985 (2.300-9.050)
Platelet count, 109/L 141 (44-259)
Hemoglobin, g/dL 136.5 (98.0-165.0)
Serum AST, IU/L 28.2 (15.0-103.7)
Serum ALT, IU/L 32.15 (8.40-74.30)
Serum total bilirubin, mg/dL 14.45 (5.40-44.80)
Serum albumin, g/dL 37.75 (24.30-46.30)
INR 1.08 (0.95-1.41)
Serum creatinine, mg/dL 65.7 (45.4-134.6)
Serum AFP, ng/mL, baseline < 20 5.60 (1.12-24200.00) (n = 29)
Serum AFP, ng/mL, baseline > 20 916.2 (21.1-24200.0) (n = 17)

WBC: White blood cell; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; INR: International Normalized Ratio; AFP: α-fetoprotein.